XML 22 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2019   47,654,929      
Beginning balance at Dec. 31, 2019 $ 1,311,192 $ 476 $ 465,652 $ 891,526 $ (46,462)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,404)     (6,404)  
Other comprehensive income, net of tax expense (8,006)       (8,006)
Exercise of stock options (in shares)   41,530      
Exercise of stock options 952   1,583 (631)  
Vested restricted stock (in shares)   177,496      
Vested restricted stock 0 $ 2 (2)    
Repurchase and retirement of common stock (in shares)   (760,532)      
Repurchase and retirement of common stock (62,966) $ (7) (11,116) (51,843)  
Share based compensation 6,313   6,313 0  
Ending balance (in shares) at Mar. 31, 2020   47,113,423      
Ending balance at Mar. 31, 2020 1,241,081 $ 471 462,430 832,648 (54,468)
Beginning balance (in shares) at Dec. 31, 2020   44,346,630      
Beginning balance at Dec. 31, 2020 1,211,018 $ 443 456,274 809,107 (54,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 77,922     77,922  
Other comprehensive income, net of tax expense $ (8,424)       (8,424)
Exercise of stock options (in shares) 15,117 15,117      
Exercise of stock options $ 444   444    
Vested restricted stock (in shares)   235,939      
Vested restricted stock 0 $ 2 (2)    
Repurchase and retirement of common stock (in shares)   (108,287)      
Repurchase and retirement of common stock (12,179)   (7,221) (4,958)  
Share based compensation 6,113   6,113    
Other, net 17   17    
Ending balance (in shares) at Mar. 31, 2021   44,489,399      
Ending balance at Mar. 31, 2021 $ 1,274,911 $ 445 $ 455,625 $ 882,071 $ (63,230)